MedPath
HSA Approval

DEXTRAMINE TABLET 2 mg

SIN09373P

DEXTRAMINE TABLET 2 mg

DEXTRAMINE TABLET 2 mg

June 13, 1997

PHARMATECH MEDICAL ENTERPRISE PTE LTD

PHARMATECH MEDICAL ENTERPRISE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMATECH MEDICAL ENTERPRISE PTE LTD
Licence HolderPHARMATECH MEDICAL ENTERPRISE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R06AB02

dexchlorpheniramine

Manufacturer Information

PHARMATECH MEDICAL ENTERPRISE PTE. LTD.

CHULIA PHARMA SDN BHD

Active Ingredients

DEXCHLORPHENIRAMINE MALEATE

2 mg

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DEXTRAMINE TABLET 2 mg - HSA Approval | MedPath